MRI or CT for Suspected Acute Stroke: Association of Admission Image Modality with Acute Recanalization Therapies, Workflow Metrics and Outcomes.
Options
BORIS DOI
Date of Publication
August 2022
Publication Type
Article
Division/Institute
Contributor
Bonati, Leo H | |
Carrera, Emmanuel | |
Vargas, Maria I | |
Platon, Alexandra | |
Kulcsar, Zsolt | |
Wegener, Susanne | |
Luft, Andreas | |
Michel, Patrik | |
Strambo, Davide | |
Dunet, Vincent | |
De Marchis, Gian Marco | |
Schelosky, Ludwig | |
Andreisek, Gustav | |
Barinka, Filip | |
Peters, Nils | |
Fisch, Loraine | |
Nedeltchev, Krassen | |
Cereda, Carlo W | |
Kägi, Georg | |
Bolognese, Manuel | |
Salmen, Stephan | |
Sturzenegger, Rolf | |
Medlin, Friedrich | |
Berger, Christian | |
Renaud, Susanne | |
Bonvin, Christophe | |
Schaerer, Michael | |
Mono, Marie-Luise | |
Rodic, Biljana | |
Psychogios, Marios | |
Subject(s)
Series
Annals of neurology
ISSN or ISBN (if monograph)
1531-8249
Publisher
Wiley-Blackwell
Language
English
Publisher DOI
PubMed ID
35599442
Description
OBJECTIVE
To examine rates of intravenous thrombolysis (IVT), mechanical thrombectomy (MT), door-to-needle (DTN) time, door-to-puncture(DTP) time, and functional outcome between patients with admission MRI versus CT.
METHODS
Observational cohort study of consecutive patients using a target trial design within the nationwide Swiss-Stroke-Registry from 01/2014 to 08/2020. Exclusion criteria included MRI contraindications, transferred patients, and unstable or frail patients. Multilevel mixed-effects logistic regression with multiple imputation was used to calculate adjusted odds ratios with 95% confidence intervals for IVT, MT, DTN, DTP, and good functional outcome (mRS 0-2) at 90 days.
RESULTS
Of the 11049 patients included (mean [SD] age, 71 [15] years; 4811 [44%] females; 69% ischemic stroke, 16% transient ischemic attack, 8% stroke mimics, 6% intracranial hemorrhage), 3741 (34%) received MRI and 7308 (66%) CT. Patients undergoing MRI had lower NIHSS (median [IQR] 2 [0-6] versus 4 [1-11]), and presented later after symptom onset (150 versus 123 min, P<.001). Admission MRI was associated with: lower adjusted odds of IVT (aOR 0.83, 0.73-0.96), but not with MT (aOR 1.11, 0.93-1.34); longer adjusted DTN (+22 min [13-30]), but not with longer DTP times; and higher adjusted odds of favorable outcome (aOR 1.54, 1.30-1.81).
INTERPRETATION
We found an association of MRI with lower rates of IVT and a significant delay in DTN, but not in DTP and rates of MT. Given the delays in workflow metrics, prospective trials are needed to show that tissue-based benefits of baseline MRI compensate for the temporal benefits of CT. This article is protected by copyright. All rights reserved.
To examine rates of intravenous thrombolysis (IVT), mechanical thrombectomy (MT), door-to-needle (DTN) time, door-to-puncture(DTP) time, and functional outcome between patients with admission MRI versus CT.
METHODS
Observational cohort study of consecutive patients using a target trial design within the nationwide Swiss-Stroke-Registry from 01/2014 to 08/2020. Exclusion criteria included MRI contraindications, transferred patients, and unstable or frail patients. Multilevel mixed-effects logistic regression with multiple imputation was used to calculate adjusted odds ratios with 95% confidence intervals for IVT, MT, DTN, DTP, and good functional outcome (mRS 0-2) at 90 days.
RESULTS
Of the 11049 patients included (mean [SD] age, 71 [15] years; 4811 [44%] females; 69% ischemic stroke, 16% transient ischemic attack, 8% stroke mimics, 6% intracranial hemorrhage), 3741 (34%) received MRI and 7308 (66%) CT. Patients undergoing MRI had lower NIHSS (median [IQR] 2 [0-6] versus 4 [1-11]), and presented later after symptom onset (150 versus 123 min, P<.001). Admission MRI was associated with: lower adjusted odds of IVT (aOR 0.83, 0.73-0.96), but not with MT (aOR 1.11, 0.93-1.34); longer adjusted DTN (+22 min [13-30]), but not with longer DTP times; and higher adjusted odds of favorable outcome (aOR 1.54, 1.30-1.81).
INTERPRETATION
We found an association of MRI with lower rates of IVT and a significant delay in DTN, but not in DTP and rates of MT. Given the delays in workflow metrics, prospective trials are needed to show that tissue-based benefits of baseline MRI compensate for the temporal benefits of CT. This article is protected by copyright. All rights reserved.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
Fischer_AnnNeurol_2022.pdf | text | Adobe PDF | 305.33 KB | published |